Results 251 to 260 of about 139,619 (346)

CD44 Occupancy Prevents Macrophage Multinucleation

, 1998
Hyacinth Sterling, Charles Saginario, Agnès Vignery   +2 more
openalex   +1 more source

Therapy with antibodies against CD40L (CD154) and CD44-variant isoforms reduces experimental autoimmune encephalomyelitis induced by a proteolipid protein peptide [PDF]

, 1998
J.D. Laman, C.B.M. Maassen, M.M. Schellekens, L. Visser, M. Kap, E. de Jong, M. van Puijenbroek, Marianne J.B. van Stipdonk, M. van Meurs, C. Schwärzler, U. Günthert   +10 more
openalex   +1 more source

Enhancing Chemotherapy‐Related Immune Responses via Bioorthogonal Metabolic Engineering‐Driven Tumor Exosomes Elimination

Advanced Science, EarlyView.
In this work, a novel strategy named bioorthogonal reaction‐driven exosome elimination (Biordee) strategy was developed to inhibit chemotherapy‐associated breast cancer metastasis and enhance the immune response. Biordee possessed the capacity of in‐situ editing tumor‐derived exosomes (TExo) with IgG Fc and promoted macrophage phagocytosis of ...
Wentao Zhang, Tianyi Yang, Tian Jin, Tianyi Zhu, Fang Hao, Miao Fan, Yanrong Zhang   +6 more
wiley   +1 more source

Alpha-1 antitrypsin modulates neutrophil phenotype and function: implications for inflammatory regulation. [PDF]

J Leukoc Biol
Oshins R, Patel I, Khartabil L, Katikaneni DS, Scindia Y, Khodayari N.   +5 more
europepmc   +1 more source

Rapid‐Turnaround Co‐Administration of mRNA‐Based MHC‐I and MHC‐II‐Restricted Neoantigens Enhances Immune Responses of Antigen‐Specific CD8+ T Cells and Anti‐Cancer Efficacy in Colorectal Cancer

Advanced Science, EarlyView.
Co‐administration with MHC class I‐ and II‐restricted neoantigens encoding mRNA‐based personalized cancer vaccines in a mouse CRC model can induce antigen‐specific immune responses and anti‐cancer effects. Notably, vaccination at an early stage of cancer development can have potent anti‐cancer effects. Furthermore, combining mRNA with immune checkpoint
Seongje Cho, Woori Kwak, Hyunho Yoon, Jisun Lee, Seonghyun Lee, Hyo‐Jung Park, Sohee Jo, Yu‐Sun Lee, Yu‐Jeong Seo, Youngran Cho, Seo‐Hyeon Bae, Subin Yoon, Gahyun Roh, Dahyeon Ha, Ayoung Oh, Eun‐Jin Choi, Soo‐Yeon Lee, Huijeong Choi, Jungmin Kim, Yeeun Lee, Sowon Lee, Sang‐In Park, Dae‐Keun Kim, Jun Chang, Ki Tae Kim, Kwoneel Kim, Jae‐Hwan Nam   +26 more
wiley   +1 more source

Impact of neoadjuvant therapy on cancer stem cell gene expression and miRNA profiles in breast cancer patients: Implications for therapy resistance and survival, a cross-sectional observational study. [PDF]

Medicine (Baltimore)
Kökenek Ünal TD, Kaplan Yilmaz MB, Kandemir O, Yora S, Taheri S.   +4 more
europepmc   +1 more source

Cutting Edge: An Inducible Sialidase Regulates the Hyaluronic Acid Binding Ability of CD44-Bearing Human Monocytes [PDF]

, 1999
Shigeki Katoh, Taeko Miyagi, Haruko Taniguchi, Yuichi Matsubara, Jun‐ichi Kadota, Akira Tominaga, Paul W. Kincade, Shigeru Matsukura, Shigeru Kohno   +8 more
openalex   +1 more source

CD44+ Cells in Head and Neck Squamous Cell Carcinoma Suppress T-Cell–Mediated Immunity by Selective Constitutive and Inducible Expression of PD-L1

Clinical Cancer Research, 2016
Yunqin Lee, J. Shin, M. Longmire, Hua Wang, H. Kohrt, Howard Y. Chang, J. Sunwoo   +6 more
semanticscholar   +1 more source

Nanoshield‐Assisted Viral Gene Therapy with Induction of Non‐Apoptotic Cell Death and Durable Antitumor Immunity

Advanced Science, EarlyView.
A novel hybrid gene delivery platform combines adeno‐associated virus (AAV)‐mediated receptor‐interacting kinase 3 (RIPK3) expression with manganese dioxide‐polyethyleneimine (MnO2−PEI) nanoshield to induce necroptosis, ferroptosis, and immunogenic cell death, effectively reprogramming the tumor microenvironment.
Soo‐Hwan Lee, Yunkyeong Cho, Seunghwan Bang, Daeun Sung, Jahyun Koo, Seoyoung Kim, Youngil Koh, Hojun Kim, Hyojin Lee   +8 more
wiley   +1 more source

Isocitrate Dehydrogenase-Wildtype Glioma Adapts Toward Mutant Phenotypes and Enhanced Therapy Sensitivity Under D-2-Hydroxyglutarate Exposure. [PDF]

Biomedicines
Rocha G, Francés-Gómez C, Megías J, Muñoz-Hidalgo L, Casanova P, Haro-Estevez JF, Teruel-Martí V, Monleón D, San-Miguel T.   +8 more
europepmc   +1 more source